Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valves

BACKGROUND: Patients with severe tricuspid valve stenosis or dysfunction following degeneration of biological valve prosthesis in tricuspid position are complex, have substantial comorbidity, and very high surgical risk. CASE SUMMARY: We report two cases with transcatheter tricuspid valve-in-valve i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Rebekka Vibjerg, Jensen, Jesper Khedri, Christiansen, Evald Høj, Tang, Mariann, Nielsen, Jens Cosedis, Terkelsen, Christian Juhl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007432/
https://www.ncbi.nlm.nih.gov/pubmed/35434509
http://dx.doi.org/10.1093/ehjcr/ytac131
Descripción
Sumario:BACKGROUND: Patients with severe tricuspid valve stenosis or dysfunction following degeneration of biological valve prosthesis in tricuspid position are complex, have substantial comorbidity, and very high surgical risk. CASE SUMMARY: We report two cases with transcatheter tricuspid valve-in-valve implantation in patients with degenerated tricuspid bioprosthesis with transfemoral and transjugular access with Sapien 3 valve and MyVal, respectively. DISCUSSION: In patients with high surgical risk, transcatheter tricuspid valve implantation is a good alternative. Careful consideration of optimal access site, device size, and delivery system is paramount. This case report demonstrates technically feasible and safe transcatheter valve-in-valve implantantion in tricuspid position and highlights the importance of meticulous procedure planning.

Ejemplares similares